Kookjeon Pharmaceutical Co., Ltd. (307750.KQ) has a MoatMap StockRank of 16/100 based on Quality (41/100), Value (34/100), and Momentum (26/100) factor scores. The current signal is STRONG SELL.
Kookjeon Pharmaceutical Co., Ltd. operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services.
| Price | $1.58 |
| Market Cap | $80M |
| Price/Book | 1.25 |
| Return on Equity | -7.9% |
| Return on Invested Capital | -0.4% |
| Debt/Equity | 37.26 |
| Gross Margin | 15.3% |
| Operating Margin | 7.7% |
| Revenue Growth | -9.4% |
| Dividend Yield | 0.3% |
| Free Cash Flow | $-11.03 |
Kookjeon Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (South Korea).